---
title: "Aristo Bio-Tech & Lifescience Ltd (ARISTO) — Share Price, Financials & Analysis"
symbol: "ARISTO"
company: "Aristo Bio-Tech & Lifescience Ltd"
canonical: "https://tapetide.com/stocks/ARISTO"
isin: "INE082101010"
nse_symbol: "ARISTO"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 73.52
generated_at: "2026-09-13T19:22:00.041Z"
---

# Aristo Bio-Tech & Lifescience Ltd (ARISTO)

Canonical page: https://tapetide.com/stocks/ARISTO

## Company

- **NSE Symbol:** ARISTO
- **ISIN:** INE082101010
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2023-01-30
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aristobiotech.com

## About

Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and  supplies pesticides and agrochemicals[1]

## Latest Price

- **Price:** ₹108
- **Change:** 0 (0%)
- **Open:** ₹108
- **Day High:** ₹108
- **Day Low:** ₹108
- **Previous Close:** ₹108
- **Volume:** 0
- **As Of:** 2026-09-11T10:01:43+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:59.384831Z.

- **Market Cap:** ₹73.52 Cr
- **Classification:** SME
- **P/E (reported):** 10.2
- **Book Value:** ₹65.39
- **Price to Book:** 1.65
- **Dividend Yield:** 0.46%
- **ROE:** 10.88%
- **ROCE:** 15.82%
- **Debt to Equity:** 0.78
- **Revenue (yearly):** ₹363.72 Cr
- **Net Income:** ₹7.12 Cr
- **EBITDA:** ₹16.05 Cr
- **52-Week High:** ₹140
- **52-Week Low:** ₹74.3
- **RSI (14):** 55.36

## Key Insights

### Strengths

- Company has delivered good profit growth of 46.1% CAGR over last 5 years

### Weaknesses

- Company has a low return on equity of 13.9% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 31.84% | 460.43% | 339.47% |
| ebitda margin growth | 44.59% | 24.93% | 33.23% |
| net income growth | 73.66% | 26% | 46% |
| revenue growth | 14.2% | 19% | 17% |
| roce | -2.59% | -14.81% | 16.34% |
| roe | -6.13% | 11.43% | 35.32% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 73 | 129 | 89 | 133 | 112 | 214 | 104 | 256 | 107 |
| Expenses | 72 | 124 | 85 | 128 | 109 | 206 | 103 | 249 | 99 |
| Operating Profit | 1 | 5 | 4 | 5 | 3 | 8 | 1 | 8 | 8 |
| OPM % | 1.2 | 3.9 | 4.1 | 4 | 2.9 | 3.8 | 1.1 | 3.1 | 8 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -1 | 4 | 1 | 4 | 2 | 6 | -1 | 6 | 4 |
| Tax % | -35 | 28 | 13 | 28 | 27 | 25 | -18 | 25 | 27 |
| Net Profit | 0 | 3 | 1 | 3 | 1 | 5 | 0 | 4 | 3 |
| EPS in Rs | -0.48 | 3.8 | 1.47 | 3.78 | 1.94 | 6.68 | -0.72 | 6.13 | 4.42 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 318 | 364 |
| Expenses | 157 | 263 | 195 | 197 | 163 | 160 | 209 | 236 | 309 | 348 |
| Operating Profit | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 9 | 16 |
| OPM % | 1.6 | 2.7 | 3.4 | 2.2 | 2.6 | 3.3 | 4 | 3.5 | 2.9 | 4.4 |
| Other Income | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 5 | 10 |
| Tax % | 31 | 34 | 31 | 28 | 28 | 28 | 25 | 28 | 26 | 26 |
| Net Profit | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | 7 |
| EPS in Rs | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.14 | 5.23 | 5.73 | 5.96 | 10.55 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 7 | 8 | 6 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 |
| Reserves | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 | 38 |
| Borrowings | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 22 | 35 |
| Other Liabilities | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 81 | 75 |
| Total Liabilities | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Fixed Assets | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | 24 |
| CWIP | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | 131 |
| Total Assets | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 | 8 |
| Cash from Investing Activity | 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 | -3 |
| Cash from Financing Activity | 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 | -4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 0 | 2 |
| Free Cash Flow | -4 | 0 | 6 | -1 | 0 | 4 | -7 | 1 | 5 | 5 |
| CFO/OP | -123 | 38 | 138 | 40 | 60 | 134 | -17 | 106 | 123 | 69 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 | 65 | 55 |
| Inventory Days | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 | 59 | 70 |
| Days Payable | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 | 97 | 78 |
| Cash Conversion Cycle | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 | 26 | 46 |
| Working Capital Days | 14 | 14 | 15 | 20 | 28 | 25 | 37 | 31 | 22 | 25 |
| ROCE % | 31 | 34 | 24 | 14 | 11 | 12 | 16 | 13 | 12 | 20 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.37% | 73.37% | 73.37% | 73.37% | 73.42% | 73.42% | 73.42% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 22.14% | 22.84% | 24.18% | 23.69% | 23.1% | 24.14% | 24.28% |
| Others | 4.49% | 3.78% | 2.44% | 2.94% | 3.48% | 2.44% | 2.3% |
| No. of Shareholders | 660 | 652 | 742 | 625 | 512 | 468 | 453 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 7 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 107.98 | Buy |
| EMA (10) | 106.24 | Buy |
| SMA (20) | 104.09 | Buy |
| EMA (20) | 105.04 | Buy |
| SMA (50) | 101.64 | Buy |
| EMA (50) | 103.25 | Buy |
| SMA (100) | 102.9 | Buy |
| EMA (100) | 105.41 | Buy |
| SMA (200) | 114.19 | Sell |
| EMA (200) | 110.39 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.48 | Neutral |
| MACD (12,26,9) | 1.65 | Sell |
| Stochastic (14,3,3) | 47.8 | Neutral |
| ADX (14) | 16.26 | Neutral |
| Williams %R (14) | -46.2 | Neutral |
| ATR (14) | 2.78 | Neutral |
| ROC (12) | 3.05 | Buy |
| Stoch RSI (14) | 40.74 | Neutral |
| UO (7,14,28) | 52.57 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Sep - Newspaper advertisement for 21st AGM on September 30, 2026, via VC/OAVM with e-voting details. | [Copy of Newspaper Publication 8 Sep - Newspaper advertisement for 21st AGM on September 30, 2026, via VC/OAVM with e-voting details.](https://nsearchives.nseindia.com/corporate/ARISTO_08092026211750_Covering_sd.pdf) |
| 8 Sep - 21st AGM on September 30, 2026; ₹0.60 final dividend proposed, record date September 23, 2026. | [Shareholders meeting 8 Sep - 21st AGM on September 30, 2026; ₹0.60 final dividend proposed, record date September 23, 2026.](https://nsearchives.nseindia.com/corporate/ARISTO_08092026210345_final_notice_sd.pdf) |
| 7 Sep - Board approved WTD and independent director reappointments, FY27 cost auditor, AGM on September 30, 2026, dividend record date September 23. | [Record Date 7 Sep - Board approved WTD and independent director reappointments, FY27 cost auditor, AGM on September 30, 2026, dividend record date September 23.](https://nsearchives.nseindia.com/corporate/ARISTO_07092026201811_BM.pdf) |
| 7 Sep - Board approved reappointments, cost auditor, Rs.0.60 final dividend record date September 23, 2026, and AGM on September 30. | [Outcome of Board Meeting 7 Sep - Board approved reappointments, cost auditor, Rs.0.60 final dividend record date September 23, 2026, and AGM on September 30.](https://nsearchives.nseindia.com/corporate/ARISTO_07092026201412_BM.pdf) |
| 7 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.](https://nsearchives.nseindia.com/corporate/ARISTO_07072026110646_Regulation_74_5__Aristo_sd.pdf) |
| 5 March 2026 - Received USD 144,000 purchase order from AVIMA (Pty) Ltd for chemicals; shipment by May 1, 2026; payment within 90 days. | [Bagging/Receiving of orders/contracts 5 March 2026 - Received USD 144,000 purchase order from AVIMA (Pty) Ltd for chemicals; shipment by May 1, 2026; payment within 90 days.](https://nsearchives.nseindia.com/corporate/ARISTO_05032026172128_sd.pdf) |
| 4 April 2026 - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 4 April 2026 - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/ARISTO_04042026145601_Reg_74_5__merged_sd.pdf) |
| 30 May - Board approved FY26 audited results, unmodified audit opinion, and recommended Rs0.60 final dividend per share. | [Outcome of Board Meeting 30 May - Board approved FY26 audited results, unmodified audit opinion, and recommended Rs0.60 final dividend per share.](https://nsearchives.nseindia.com/corporate/ARISTO_30052026151838_outcome-final.pdf) |
| 30 May - Board approved FY26 audited results, recommended Rs0.60 final dividend, and reported unmodified audit opinion. | [Dividend 30 May - Board approved FY26 audited results, recommended Rs0.60 final dividend, and reported unmodified audit opinion.](https://nsearchives.nseindia.com/corporate/ARISTO_30052026152936_outcome-final.pdf) |
| 30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after results for period ending March 31, 2026. | [Trading Window 30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after results for period ending March 31, 2026.](https://nsearchives.nseindia.com/corporate/ARISTO_30032026125652_TWC.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31958_ARISTO_2025_2026_A_3192789_08092026210634.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27450_ARISTO_2024_2025_A_14082025191438.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25296_ARISTO_2023_2024_2908202419105.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23430_ARISTO_2022_2023_04092023191322_09042023200019.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0deaad41-c2d4-45f3-b342-cc98acc09e1a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7c1bd6b-1af1-4bc7-9bd5-b4fb047e2bcd.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d68ee625-6c46-4cab-865b-61ffa1ee13cc.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526506/75198526506.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/526506/70935526506.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/526506/66015526506.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b82b923-9480-40ef-bdbe-09b54c167323.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29da0e53-5744-4d6f-9df0-947774998f84.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8690807e-7ea5-43ae-a97d-7521ef50ea2f.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4b0bdd05-2c14-4c1e-aff9-34dd87a07ee0.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eba6c7d0-824b-4d37-898d-6fcb0f3ade2a.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5905c087-c782-4adb-a13a-74739b7ef2ed.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:22:00.041Z.